Corporate Information

Kinexus is striving to be a world leader in development and application of proteomics and bioinformatics for the discovery of novel diagnostics and therapeutics based on leading-edge knowledge of cellular communication systems. To this end, we have created a unique business model where our clients are also our valued partners in the common pursuit of knowledge for the betterment of human health. Our shareholders are not only seeking a financial return on their investment, but they also want their investment to foster the development of personalized medicine to reduce disease and improve human wellfare.